sefulness and safetyOf Cryotherapy versus Bleomycin injection in the treatment of localised keloids.
Phase 4
- Conditions
- Health Condition 1: L910- Hypertrophic scar
- Registration Number
- CTRI/2020/08/027352
- Lead Sponsor
- Bankura Sammilani Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Age more than 18 yrs. to 80 yrs.
2 Previously not treated keloid
3 Localised keloid
4 Informed consent obtained
5 Willing for once monthly treatment with spray cryotherapy or intralesional bleomycin injection.
Exclusion Criteria
1 Keloid in children.
2 Pregnant and lactating women.
3 Infected or ulcerated keloid.
4 Patients suffering from peripheral vascular disease.
5 Raynaudâ??s phenomenon
6 Concomitant immune defect, heart disease, renal failure, malignancy.
7 Neurological or psychiatric disorders.
8 Participation in any clinical trial within the last 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess effectiveness of Cryotherapy versus Intralesional Bleomycin injection in reducing the thickness of localised keloid.Timepoint: 6 months
- Secondary Outcome Measures
Name Time Method To assess the effectiveness of these two different methods in decreasing pain and itching associated with keloid.Timepoint: 6 months;To assess the improvement in quality of life with these mentioned methodsTimepoint: 6 months;To assess tolerability and safety of the mentioned methods.Timepoint: 6 months